has shown that the drugs' physico-chemical profile, rather than hydrophobicity alone, dictate their bilayer-modifying potency. As drugs traverse varying environments, i.e. pH differences in segments of the gastro intestinal system, the ensuing changes in drug charge may alter bilayer partitioning, such that a drug's pKa and the local pH (which determine the net drug charge) may affect its interactions with cell membranes (and proteins). We explore this question using gramicidin channels as reporters to quantify amphiphile effects on lipid bilayer properties. We previously reported that amiodarone and troglitazone alter bilayer elasticity at their clinical concentrations. To understand how pH affects drug interactions with the lipid bilayer, we examine changes in bilayer-modifying potency of a group of drugs with varying pKa, including amiodarone and troglitazone. As we vary their charge by changing pH to below and above their respective pKa, we find that increasing the charged population results in increased bilayermodifying potency even though the bilayer partition coefficients of charged compounds tend to be less than their neutral counterparts. The increased bilayer-modifying potency of charged compounds may be due to altered localization of charged compounds at the interface. We conclude that drug interactions with lipid bilayer, and their effect on bilayer properties, are highly dependent on its environment. We have developed a new 14-residue antimicrobial peptide template sequence containing four residues: L, D, K, and A. This template, called LDKA, which was designed using atomic detail structural information derived from unbiased long-timescale equilibrium molecular dynamics folding, partitioning, and pore assembly simulations, shows low micro-molar antibacterial activity against several gram-positive and gram-negative bacteria. Furthermore, LDKA was shown to form pores in microbial and eukaryotic membrane models using fluorescent dye leakage assays. A library of 2,916 peptides was designed using this template sequence and high-throughput screened using an orthogonal vesicle leakage assay. Dyes of different sizes were embedded into vesicles with varying lipid composition to simultaneously screen for both pore size and affinity to charged and neutral membranes. From this screen, 9 different LDKA variants were selected, sequenced, synthesized, and further characterized biophysically. Remarkably, even though the selected sequences displayed only minor mutational changes, each of these peptides has unique functional properties, forming either small or large pores and being selective for either neutral or anionic charged bilayers. Further screening of these peptides for bacterial and haemolytic activity revealed good correlation between charged membrane model leakage and antibacterial activity, as well as neutral membrane leakage and haemolytic activity. Antimicrobial activity is different for each peptide and depends on the bacterial species. Analysis of the sequences reveals no clear motifs or explanation for these strong preferences, but suggests that hydrophobic moment and sequence arrangement are more important for membrane selectivity than net charge. The results reveal that simple sequence-function relationships for peptides that can form a large repertoire of functional structures may remain elusive and that it may be the peptide sequences propensity to aggregate and assemble in a given environment that holds the key to functional prediction.
We have developed a new 14-residue antimicrobial peptide template sequence containing four residues: L, D, K, and A. This template, called LDKA, which was designed using atomic detail structural information derived from unbiased long-timescale equilibrium molecular dynamics folding, partitioning, and pore assembly simulations, shows low micro-molar antibacterial activity against several gram-positive and gram-negative bacteria. Furthermore, LDKA was shown to form pores in microbial and eukaryotic membrane models using fluorescent dye leakage assays. A library of 2,916 peptides was designed using this template sequence and high-throughput screened using an orthogonal vesicle leakage assay. Dyes of different sizes were embedded into vesicles with varying lipid composition to simultaneously screen for both pore size and affinity to charged and neutral membranes. From this screen, 9 different LDKA variants were selected, sequenced, synthesized, and further characterized biophysically. Remarkably, even though the selected sequences displayed only minor mutational changes, each of these peptides has unique functional properties, forming either small or large pores and being selective for either neutral or anionic charged bilayers. Further screening of these peptides for bacterial and haemolytic activity revealed good correlation between charged membrane model leakage and antibacterial activity, as well as neutral membrane leakage and haemolytic activity. Antimicrobial activity is different for each peptide and depends on the bacterial species. Analysis of the sequences reveals no clear motifs or explanation for these strong preferences, but suggests that hydrophobic moment and sequence arrangement are more important for membrane selectivity than net charge. The results reveal that simple sequence-function relationships for peptides that can form a large repertoire of functional structures may remain elusive and that it may be the peptide sequences propensity to aggregate and assemble in a given environment that holds the key to functional prediction.
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Modeling of Peptide Folding and Translocation across Membranes Andrei L. Lomize, Irina Pogozheva. College of Pharmacy, University of Michigan, Ann Arbor, MI, USA. A theoretical approach for fast computational modeling of three-dimensional (3D) structure, binding, folding, and passive diffusion of peptides across the lipid bilayer was developed. This method combines a thermodynamic model for a-helix and b-sheet formation, energy refinement of all-atom models, positioning of the molecules in the bilayer using an anisotropic solvent model, and optimization of the rotational orientation of the molecule in every point of the transmembrane trajectory to find the lowest energy translocation pathway. Calculation results are consistent with experimental studies of more than 300 peptides in micelles and membranes, including their secondary structure, membrane binding energies and tilt angles. Modeling of translocation pathways shows that energy barriers can be decreased by rotating peptide to adopt perpendicular orientation to the membrane plane. Low passive permeability of polar peptides across the planar lipid bilayer may be improved upon thinning or other significant deformations of the bilayer. The computational method can also be used for cyclic peptides and small proteins with known structure. The method was implemented into a web server that is available through the CellPM website. This web server uses as an input the amino acid sequence or 3D structure of a peptide in PDB format. As an output, the server produces the following data: (1) peptide structure and parameters of its association with the membrane, including energy of membrane binding, penetration depth and tilt angle; (2) energy profile of a peptide along the membrane normal; (3) the log of the permeability coefficient that defines the ability of a peptide to passively cross the lipid bilayer; (4) downloadable coordinate file with optimized peptide structures along the lowest energy translocation pathway; and (5) the visualization of a peptide translocation pathway across the membrane with GLmol. Many central nervous system (CNS) diseases (e.g. brain cancer, Alzheimer disease) do not have an effective drug therapy. The major challenge lies in crossing the blood-brain barrier (BBB), which separates the circulating blood from the brain. Cell-penetrating peptides (CPPs) have been proposed as a potential drug delivery vehicle across the BBB. However, while CPPs can enter cells, many cannot efficiently translocate across to deliver drugs. We have identified a CPP, called the CL peptide, that demonstrates an ability to deliver a small-molecule cargo across an in vitro epithelial barrier at a moderately high rate. In this study, we investigate the effect of secondary structure, charge, hydrophobicity, cargo, and other parameters on the barrier-penetrating property of the CL peptide. A family of histidine-rich peptides LAH4 was designed using linear cationic peptides such as magainins as a template. These designed peptides have been shown to exhibit considerable antimicrobial, nucleic acid transfection as well as cell penetrating activities. In contrast to their natural templates their membrane interactions are strongly pH dependent. The delivery of cargo by these peptides is complex, involving many steps, which we investigated on a structural and biophysical level. Recently, vectofusin-1, a member of the family of LAH4 peptides has been shown to spontaneously self-assemble into helical coiled-coil structures, spherical aggregates, that further assemble into annular and extended nanofibrils and hydrogels as a function of phosphate and in a pH-dependent manner. This bears considerable interest for the design of biomaterials. Furthermore, the peptide has a strong capacity to enhance the gene transfer by lenti-and adeno associated viruses into the cell interior. Thereby, the fibers formed by this short peptide have gene therapeutic applications ranging from monogenic and infectious diseases to cancer, by enhancing transduction levels of target cells and reducing the amount of lentivirus for greater safety and reduced costs. Vectofusin-1 promotes the entry of several retroviral pseudotypes into target cells when added to the culture medium, without cytotoxicity. These associate with viral particles allowing them to be easily pelleted. These fibrils have a unique coiled-coil a-helical structure whereas most other viral transduction enhancers form b-amyloid fibrils. Our observations define vectofusin-1 as a member of a new class of a-helical lentiviral transduction enhancers. Its coiled-coil fibril formation is reversible which bears considerable advantages in handling the peptide in conditions well-adapted to scalable gene therapy protocols. References: J PepSci 21, 346 (2015) , JPC B 119, 9678 (2015) , JBC 291, 2161 JBC 291, (2016 , Acta Biomat (2017 in press), SciRep 7:9585 (2017). Monday, February 19, 2018 267a 
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